Fig. 2From: Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancerNiclosamide potentiates anti-PD-L1 efficacy in vivo. a-c Tumor volumes determined at the indicated days with different treatments in C57BL/6 mice (n = 6). Error bars represent SD of three independent experiments. d Survival analysis of C57BL/6 mice with different treatments (n = 6). e-h Immunohistochemistry staining of CD3 and Granzyme B in xenograft tumors (n = 6). * P < 0.05, ** P < 0.01, *** P < 0.001Back to article page